Exploring the Use of a Participative Design in the Early Development of a Predictive Test: The Importance of Physician Involvement

Public Health Genomics. 2017;20(3):174-187. doi: 10.1159/000479289. Epub 2017 Aug 17.

Abstract

In this study, we contribute to the personalized medicine and health care management literature by developing and testing a new participative design approach. We propose that involving gastroenterologists in the development of a predictive test to assist them in their clinical decision-making process for the treatment of inflammatory bowel diseases will increase the likelihood of their acceptance of the innovation. Based on data obtained from 6 focus groups across Canada from a total of 28 physicians, analyses reveal that current tools do not enable discriminating between treatment options to find the best fit for each patient. Physicians expect a new predictive tool to have the capability of showing clear reliability and significant benefits for the patient, while being accessible in a timely manner that facilitates clinical decisions. Physicians also insist on their key role in the implementation process, hence confirming the relevance and importance of participative designs in personalized medicine.

Keywords: Clinical decision making; Health care management; Inflammatory bowel disease; Innovation management; Participative design; Personalized medicine; Predictive testing.

MeSH terms

  • Adult
  • Aged
  • Canada
  • Clinical Decision-Making / methods
  • Female
  • Focus Groups
  • Gastroenterologists*
  • Humans
  • Inflammatory Bowel Diseases / therapy*
  • Male
  • Middle Aged
  • Patient Participation
  • Physician's Role
  • Practice Patterns, Physicians'
  • Precision Medicine / methods*
  • Reproducibility of Results

Grants and funding